A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy

Eun Seok Jeon, Sang Wook Lim, Seok Yeon Kim, Hyoung Mo Yang, Moo Hyun Kim, Moo Yong Rhee, Seung Hwan Han, Jinho Shin, Kwang il Kim, Jin Ok Jeong, Ki Chul Sung, Geu Ru Hong, Hyung Seop Kim, Kihwan Kwon, Tae Soo Kang, Hae Young Lee, Su Eun Han

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience